Who owns ROCKET PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of RCKT from SEC Form 13F filings across 137 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 137 institutions disclosed 62.2M shares of ROCKET PHARMACEUTICALS, INC. worth $212.0M — about 55.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
137
13F holders
$212.0M
value, 2026 filers
55.1%
of shares outstanding (62.2M sh)
17
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of RCKT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9.9M | $33.9M | 0.0% | 8.8% | +26.7% |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.8M | $19.9M | 0.0% | 5.1% | +23.9% |
| 3 | CITIGROUP INC | 4.9M | $16.6M | 0.0% | 4.3% | -4.7% |
| 4 | MARSHALL WACE, LLP | 4.0M | $13.8M | 0.0% | 3.6% | +32.6% |
| 5 | MILLENNIUM MANAGEMENT LLC | 4.0M | $13.7M | 0.0% | 3.5% | +28.3% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8M | $12.9M | 0.0% | 3.4% | -49.9% |
| 7 | GOLDMAN SACHS GROUP INC | 2.8M | $9.7M | 0.0% | 2.5% | +64.6% |
| 8 | Monaco Asset Management SAM | 2.5M | $8.5M | 0.7% | 2.2% | +20.5% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $8.1M | 0.0% | 2.1% | +8.3% |
| 10 | FEDERATED HERMES, INC. | 2.3M | $7.9M | 0.0% | 2% | +125.1% |
| 11 | JPMORGAN CHASE & CO | 2.0M | $6.7M | 0.0% | 1.8% | +149.7% |
| 12 | MORGAN STANLEY | 1.1M | $3.6M | 0.0% | 0.9% | -47.4% |
| 13 | D. E. Shaw & Co., Inc. | 950,552 | $3.3M | 0.0% | 0.8% | -56.2% |
| 14 | Jump Financial, LLC | 867,900 | $3.0M | 0.0% | 0.8% | +82.1% |
| 15 | Sixth Street Partners Management Company, L.P.NEW | 749,073 | $2.6M | 0.4% | 0.7% | new |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 749,073 | $2.6M | 0.0% | 0.7% | +3.4% |
| 17 | NORTHERN TRUST CORP | 735,090 | $2.5M | 0.0% | 0.7% | +14.7% |
| 18 | BANK OF AMERICA CORP /DE/ | 734,584 | $2.5M | 0.0% | 0.7% | +16.6% |
| 19 | Prosight Management, LP | 700,000 | $2.4M | 0.4% | 0.6% | +2.4% |
| 20 | Point72 Asset Management, L.P. | 670,527 | $2.3M | 0.0% | 0.6% | -33.8% |
| 21 | Qube Research & Technologies LtdNEW | 644,869 | $2.2M | 0.0% | 0.6% | new |
| 22 | Woodline Partners LP | 641,222 | $2.2M | 0.0% | 0.6% | -50.0% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 592,844 | $2.0M | 0.0% | 0.5% | +0.4% |
| 24 | FMR LLC | 488,299 | $1.7M | 0.0% | 0.4% | +5.5% |
| 25 | IEQ CAPITAL, LLC | 440,255 | $1.5M | 0.0% | 0.4% | +15.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.